BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26059931)

  • 1. Symptoms: Aromatase Inhibitor Induced Arthralgias.
    Hershman DL; Loprinzi C; Schneider BP
    Adv Exp Med Biol; 2015; 862():89-100. PubMed ID: 26059931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aromatase inhibitor-associated arthralgia syndrome.
    Burstein HJ
    Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer.
    Greenlee H; Crew KD; Shao T; Kranwinkel G; Kalinsky K; Maurer M; Brafman L; Insel B; Tsai WY; Hershman DL
    Support Care Cancer; 2013 Apr; 21(4):1077-87. PubMed ID: 23111941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.
    Crew KD; Capodice JL; Greenlee H; Brafman L; Fuentes D; Awad D; Yann Tsai W; Hershman DL
    J Clin Oncol; 2010 Mar; 28(7):1154-60. PubMed ID: 20100963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acupuncture for treatment of arthralgia secondary to aromatase inhibitor therapy in women with early breast cancer: pilot study.
    Oh B; Kimble B; Costa DS; Davis E; McLean A; Orme K; Beith J
    Acupunct Med; 2013 Sep; 31(3):264-71. PubMed ID: 23722951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility and promise of a 6-week program to encourage physical activity and reduce joint symptoms among elderly breast cancer survivors on aromatase inhibitor therapy.
    Nyrop KA; Muss HB; Hackney B; Cleveland R; Altpeter M; Callahan LF
    J Geriatr Oncol; 2014 Apr; 5(2):148-55. PubMed ID: 24495696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and management of arthralgias in breast cancer patients treated with aromatase inhibitors in an outpatient oncology clinic.
    Menas P; Merkel D; Hui W; Lawton J; Harper A; Carro G
    J Oncol Pharm Pract; 2012 Dec; 18(4):387-93. PubMed ID: 22277833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acupuncture for Aromatase Inhibitor-Induced Arthralgia: A Systematic Review.
    Bae K; Yoo HS; Lamoury G; Boyle F; Rosenthal DS; Oh B
    Integr Cancer Ther; 2015 Nov; 14(6):496-502. PubMed ID: 26220605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.
    Lintermans A; Vanderschueren D; Verhaeghe J; Van Asten K; Jans I; Van Herck E; Laenen A; Paridaens R; Billen J; Pauwels S; Vermeersch P; Wildiers H; Christiaens MR; Neven P
    Eur J Cancer; 2014 Nov; 50(17):2925-31. PubMed ID: 25304297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acupuncture for treating aromatase inhibitor-related arthralgia in breast cancer: a systematic review and meta-analysis.
    Chien TJ; Liu CY; Chang YF; Fang CJ; Hsu CH
    J Altern Complement Med; 2015 May; 21(5):251-60. PubMed ID: 25915433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of baseline serum vitamin D levels on aromatase inhibitors induced musculoskeletal symptoms: results from the IBIS-II, chemoprevention study using anastrozole.
    Singh S; Cuzick J; Mesher D; Richmond B; Howell A
    Breast Cancer Res Treat; 2012 Apr; 132(2):625-9. PubMed ID: 22198469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acupuncture and Vitamin D for the Management of Aromatase Inhibitor-Induced Arthralgia.
    Anand K; Niravath P
    Curr Oncol Rep; 2019 Apr; 21(6):51. PubMed ID: 30997616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms?
    Muslimani AA; Spiro TP; Chaudhry AA; Taylor HC; Jaiyesimi I; Daw HA
    Clin Breast Cancer; 2009 Feb; 9(1):34-8. PubMed ID: 19299238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.
    Crew KD; Greenlee H; Capodice J; Raptis G; Brafman L; Fuentes D; Sierra A; Hershman DL
    J Clin Oncol; 2007 Sep; 25(25):3877-83. PubMed ID: 17761973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations.
    Coleman RE; Bolten WW; Lansdown M; Dale S; Jackisch C; Merkel D; Maass N; Hadji P
    Cancer Treat Rev; 2008 May; 34(3):275-82. PubMed ID: 18082328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.
    Hershman DL; Unger JM; Greenlee H; Capodice JL; Lew DL; Darke AK; Kengla AT; Melnik MK; Jorgensen CW; Kreisle WH; Minasian LM; Fisch MJ; Henry NL; Crew KD
    JAMA; 2018 Jul; 320(2):167-176. PubMed ID: 29998338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase inhibitor-associated arthralgia and/ or bone pain: frequency and characterization in non-clinical trial patients.
    Presant CA; Bosserman L; Young T; Vakil M; Horns R; Upadhyaya G; Ebrahimi B; Yeon C; Howard F
    Clin Breast Cancer; 2007 Oct; 7(10):775-8. PubMed ID: 18021478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of aromatase inhibitor associated arthralgia: known and potential candidate genes and associated biomarkers.
    Borrie AE; Kim RB
    Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):149-156. PubMed ID: 27635473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for the Treatment of Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
    Yang GS; Kim HJ; Griffith KA; Zhu S; Dorsey SG; Renn CL
    Cancer Nurs; 2017; 40(4):E26-E41. PubMed ID: 27333128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of and risk factors for estrogen deprivation pain syndromes related to aromatase inhibitor treatments in women with breast cancer: a prospective multicenter cohort study.
    Laroche F; Coste J; Medkour T; Cottu PH; Pierga JY; Lotz JP; Beerblock K; Tournigand C; Declèves X; de Cremoux P; Bouhassira D; Perrot S
    J Pain; 2014 Mar; 15(3):293-303. PubMed ID: 24365325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.